Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
[This corrects the article DOI: 10.1371/journal.pone.0144359.].
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4936688?pdf=render |
_version_ | 1811221630525898752 |
---|---|
author | Hélène Bonsang-Kitzis Léonor Chaltier Lisa Belin Alexia Savignoni Roman Rouzier Anne-Sophie Hamy Marie-Paule Sablin Florence Lerebours François-Clément Bidard Paul Cottu Xavier Sastre-Garau Marick Laé Jean-Yves Pierga Fabien Reyal |
author_facet | Hélène Bonsang-Kitzis Léonor Chaltier Lisa Belin Alexia Savignoni Roman Rouzier Anne-Sophie Hamy Marie-Paule Sablin Florence Lerebours François-Clément Bidard Paul Cottu Xavier Sastre-Garau Marick Laé Jean-Yves Pierga Fabien Reyal |
author_sort | Hélène Bonsang-Kitzis |
collection | DOAJ |
description | [This corrects the article DOI: 10.1371/journal.pone.0144359.]. |
first_indexed | 2024-04-12T08:03:59Z |
format | Article |
id | doaj.art-f696ea100bd1488e82d016e80881c3c3 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-12T08:03:59Z |
publishDate | 2016-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-f696ea100bd1488e82d016e80881c3c32022-12-22T03:41:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015912310.1371/journal.pone.0159123Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.Hélène Bonsang-KitzisLéonor ChaltierLisa BelinAlexia SavignoniRoman RouzierAnne-Sophie HamyMarie-Paule SablinFlorence LereboursFrançois-Clément BidardPaul CottuXavier Sastre-GarauMarick LaéJean-Yves PiergaFabien Reyal[This corrects the article DOI: 10.1371/journal.pone.0144359.].http://europepmc.org/articles/PMC4936688?pdf=render |
spellingShingle | Hélène Bonsang-Kitzis Léonor Chaltier Lisa Belin Alexia Savignoni Roman Rouzier Anne-Sophie Hamy Marie-Paule Sablin Florence Lerebours François-Clément Bidard Paul Cottu Xavier Sastre-Garau Marick Laé Jean-Yves Pierga Fabien Reyal Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. PLoS ONE |
title | Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. |
title_full | Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. |
title_fullStr | Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. |
title_full_unstemmed | Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. |
title_short | Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. |
title_sort | correction beyond axillary lymph node metastasis bmi and menopausal status are prognostic determinants for triple negative breast cancer treated by neoadjuvant chemotherapy |
url | http://europepmc.org/articles/PMC4936688?pdf=render |
work_keys_str_mv | AT helenebonsangkitzis correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT leonorchaltier correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT lisabelin correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT alexiasavignoni correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT romanrouzier correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT annesophiehamy correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT mariepaulesablin correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT florencelerebours correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT francoisclementbidard correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT paulcottu correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT xaviersastregarau correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT maricklae correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT jeanyvespierga correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy AT fabienreyal correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy |